CME Group Valuation

Is CME * undervalued compared to its fair value, analyst forecasts and its price relative to the market?

Valuation Score

1/6

Valuation Score 1/6

  • Below Fair Value

  • Significantly Below Fair Value

  • Price-To-Earnings vs Peers

  • Price-To-Earnings vs Industry

  • Price-To-Earnings vs Fair Ratio

  • Analyst Forecast

Share Price vs Fair Value

What is the Fair Price of CME * when looking at its future cash flows? For this estimate we use a Discounted Cash Flow model.

Below Fair Value: CME * (MX$4649) is trading above our estimate of fair value (MX$2171.2)

Significantly Below Fair Value: CME * is trading above our estimate of fair value.


Key Valuation Metric

Which metric is best to use when looking at relative valuation for CME *?

Key metric: As CME * is profitable we use its Price-To-Earnings Ratio for relative valuation analysis.

The above table shows the Price to Earnings ratio for CME *. This is calculated by dividing CME *'s market cap by their current earnings.
What is CME *'s PE Ratio?
PE Ratio24.7x
EarningsUS$3.42b
Market CapUS$84.47b

Price to Earnings Ratio vs Peers

How does CME *'s PE Ratio compare to its peers?

The above table shows the PE ratio for CME * vs its peers. Here we also display the market cap and forecasted growth for additional consideration.
CompanyForward PEEstimated GrowthMarket Cap
Peer Average45.6x
BOLSA A Bolsa Mexicana de Valores. de
11.3x2.3%Mex$17.7b
ICE Intercontinental Exchange
38.1x11.4%US$92.1b
MCO Moody's
45.3x9.3%US$90.6b
LSEG London Stock Exchange Group
87.7x21.9%UK£59.7b
CME * CME Group
24.7x3.1%Mex$84.5b

Price-To-Earnings vs Peers: CME * is good value based on its Price-To-Earnings Ratio (24.7x) compared to the peer average (45.4x).


Price to Earnings Ratio vs Industry

How does CME *'s PE Ratio compare vs other companies in the South American Capital Markets Industry?

1 CompanyPrice / EarningsEstimated GrowthMarket Cap
No. of Companies8PE0612182430+
1 CompanyEstimated GrowthMarket Cap
No more companies

Price-To-Earnings vs Industry: CME * is expensive based on its Price-To-Earnings Ratio (24.7x) compared to the South American Capital Markets industry average (9.4x).


Price to Earnings Ratio vs Fair Ratio

What is CME *'s PE Ratio compared to its Fair PE Ratio? This is the expected PE Ratio taking into account the company's forecast earnings growth, profit margins and other risk factors.

CME * PE Ratio vs Fair Ratio.
Fair Ratio
Current PE Ratio24.7x
Fair PE Ration/a

Price-To-Earnings vs Fair Ratio: Insufficient data to calculate CME *'s Price-To-Earnings Fair Ratio for valuation analysis.


Analyst Price Targets

What is the analyst 12-month forecast and do we have any statistical confidence in the consensus price target?

The above table shows the analyst CME * forecast and predictions for the stock price in 12 month’s time.
DateShare PriceAverage 1Y Price TargetDispersionHighLow1Y Actual priceAnalysts
CurrentMex$4,649.00
Mex$4,888.08
+5.1%
9.0%Mex$5,695.86Mex$3,748.91n/a16
Nov ’25Mex$4,565.00
Mex$4,713.24
+3.2%
9.3%Mex$5,508.17Mex$3,625.38n/a16
Oct ’25Mex$4,247.50
Mex$4,291.98
+1.0%
8.9%Mex$4,922.00Mex$3,484.78n/a16
Sep ’25Mex$4,180.50
Mex$4,168.28
-0.3%
8.0%Mex$4,769.20Mex$3,643.67n/a14
Aug ’25Mex$3,710.80
Mex$4,020.44
+8.3%
8.3%Mex$4,610.60Mex$3,522.50n/a14
Jul ’25Mex$3,459.35
Mex$4,110.15
+18.8%
9.5%Mex$4,591.33Mex$3,434.31n/a15
Jun ’25n/a
Mex$3,792.13
0%
8.1%Mex$4,196.08Mex$3,138.66n/a15
May ’25n/a
Mex$3,894.30
0%
8.0%Mex$4,302.78Mex$3,218.48n/a15
Apr ’25Mex$3,509.00
Mex$3,752.07
+6.9%
8.9%Mex$4,157.88Mex$3,076.83n/a15
Mar ’25n/a
Mex$3,848.07
0%
8.8%Mex$4,263.00Mex$3,154.62n/a15
Feb ’25Mex$3,548.00
Mex$3,741.60
+5.5%
9.5%Mex$4,216.05Mex$3,035.56n/a15
Jan ’25n/a
Mex$3,856.16
0%
8.4%Mex$4,228.08Mex$3,044.21n/a15
Dec ’24Mex$3,707.50
Mex$4,002.93
+8.0%
8.5%Mex$4,398.18Mex$3,166.69n/a15
Nov ’24n/a
Mex$4,050.52
0%
8.5%Mex$4,453.08Mex$3,206.21Mex$4,565.0015
Oct ’24n/a
Mex$3,746.78
0%
8.6%Mex$4,392.48Mex$3,039.59Mex$4,247.5014
Sep ’24n/a
Mex$3,605.87
0%
10.4%Mex$4,282.50Mex$2,860.71Mex$4,180.5014
Aug ’24Mex$3,284.00
Mex$3,607.50
+9.9%
10.8%Mex$4,293.08Mex$2,822.62Mex$3,710.8016
Jul ’24n/a
Mex$3,525.87
0%
11.0%Mex$4,269.30Mex$2,732.35Mex$3,459.3515
Jun ’24n/a
Mex$3,636.52
0%
11.5%Mex$4,425.53Mex$2,832.34n/a14
May ’24n/a
Mex$3,714.82
0%
11.4%Mex$4,511.40Mex$2,887.30n/a14
Apr ’24n/a
Mex$3,750.08
0%
11.0%Mex$4,556.60Mex$2,916.22Mex$3,509.0016
Mar ’24n/a
Mex$3,795.68
0%
11.3%Mex$4,628.88Mex$2,962.48n/a16
Feb ’24Mex$3,270.30
Mex$3,792.53
+16.0%
11.7%Mex$4,706.10Mex$2,993.08Mex$3,548.0016
Jan ’24Mex$3,270.30
Mex$4,040.06
+23.5%
10.8%Mex$4,866.45Mex$3,133.99n/a17
Dec ’23n/a
Mex$4,065.15
0%
11.9%Mex$5,242.78Mex$3,126.25Mex$3,707.5017
Nov ’23n/a
Mex$4,151.42
0%
12.0%Mex$5,345.03Mex$3,187.22n/a17

Analyst Forecast: Target price is less than 20% higher than the current share price.


Discover undervalued companies